Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CARE: A CAnadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the Impact on Quality of Life and Work Productivity

NCT05132231 is registered in ClinicalTrials.gov with Bausch Health Americas, Inc. as lead sponsor.

NCT NCT05132231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05132231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CARE: A CAnadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the Impact on Quality of Life and Work Productivity
Lead sponsor
Bausch Health Americas, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
October 22, 2021
Completion date
December 31, 2026
Enrollment
394 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis